PharmaLundensis AB (XSAT:PHAL) 3-Year EBITDA Growth Rate : 9.90% (As of Sep. 2024)

View and export this data going back to 2010. Start your Free Trial

What is PharmaLundensis AB 3-Year EBITDA Growth Rate?

PharmaLundensis AB's EBITDA per Share for the three months ended in Sep. 2024 was kr-0.01.

During the past 3 years, the average EBITDA Per Share Growth Rate was 9.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 20.10% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 14.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of PharmaLundensis AB was 42.20% per year. The lowest was -36.70% per year. And the median was 2.65% per year.

Competitive Comparison of PharmaLundensis AB's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, PharmaLundensis AB's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmaLundensis AB's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaLundensis AB's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where PharmaLundensis AB's 3-Year EBITDA Growth Rate falls into.

PharmaLundensis AB 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

PharmaLundensis AB (XSAT:PHAL) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

PharmaLundensis AB 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of PharmaLundensis AB's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaLundensis AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaLundensis AB (XSAT:PHAL) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

PharmaLundensis AB, Scheelevagen 2, Lund, SWE, 223 63

Website

http://www.pharmalundensis.se

PharmaLundensis AB is a Sweden based drug manufacturing company, The company focuses on the development and marketing of pharmaceuticals. It is engaged in developing drugs for the lung diseases, such as chronic obstructive pulmonary disease and asthma, as well as drugs for mercury toxicology.

PharmaLundensis AB Headlines

No Headlines